Johnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies ...
Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year. Johnson & Johnson (JNJ) shares edged lower Friday after the consumer ...
There have been varied opinions from researchers and government agencies if talc-based powders increase the risk of ovarian ...
A molecular biology and microscopy expert was questioned extensively about whether there was asbestos in Johnson & Johnson's ...
(Reuters) - Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that drew ...
In 1894, Johnson & Johnson (JNJ) began selling talc as Johnson's Baby Powder. "The original square ... also narrowed its full-year and expects sales of $88 billion to $88.4 billion.
Johnson & Johnson reported first-quarter adjusted ... At the time, J&J recorded costs tied to its talc baby powder liabilities and the spinoff of its consumer health unit Kenvue.
Johnson & Johnson, the New Jersey-based company known for its pharmaceutical and medical technology, continues to push back against the narrative that its talc-based baby powder is linked with ...